Top 5 Undervalued Stocks To Buy Right Now

Using Money Morning’s proprietary VQScore™ stock valuation system, I found an undervalued dividend stock that’s flashing a huge “Buy” signal right now.

Through the system, we track the 1,500 most profitable companies on the market. A VQScore of 4.00 or higher puts a stock in the “Buy Zone.” These are the stocks priced to make you money.

And this stock is a screaming buy, with a top score of 4.75….

It’s undervalued right now because Wall Street is ignoring huge revenue growth potential thanks to international expansion.

Top 5 Undervalued Stocks To Buy Right Now: Qualys, Inc.(QLYS)

Advisors’ Opinion:

  • [By ]

    Qualys (QLYS) : “I think this is a good company, but everything is coming down, so let’s wait to buy some more.”

    HEICO (HEI) : “We’re not buying anything at a 52-week high — but on a pullback, you bet.”

  • [By ]

    In the Lightning Round, Cramer was bullish on Align Technology (ALGN) , Regions Financial (RF) , Edwards Lifesciences (EW) , Qualys (QLYS) and HEICO (HEI) .

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Qualys (QLYS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Qualys Inc  (NASDAQ:QLYS)Q4 2018 Earnings Conference CallFeb. 12, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Qualys Inc (NASDAQ:QLYS)’s share price reached a new 52-week high and low on Monday . The stock traded as low as $86.00 and last traded at $85.60, with a volume of 20160 shares changing hands. The stock had previously closed at $83.55.

Top 5 Undervalued Stocks To Buy Right Now: GenMark Diagnostics, Inc.(GNMK)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on GenMark Diagnostics (GNMK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Media coverage about GenMark Diagnostics (NASDAQ:GNMK) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. GenMark Diagnostics earned a coverage optimism score of 0.08 on Accern’s scale. Accern also gave news headlines about the medical equipment provider an impact score of 46.8084316993639 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Shane Hupp]

    BidaskClub upgraded shares of GenMark Diagnostics (NASDAQ:GNMK) from a hold rating to a buy rating in a report released on Thursday morning.

    Other analysts have also issued reports about the company. Canaccord Genuity boosted their price objective on GenMark Diagnostics from $8.00 to $9.00 and gave the stock a buy rating in a report on Friday, June 29th. ValuEngine raised GenMark Diagnostics from a strong sell rating to a sell rating in a report on Friday, August 10th. Needham & Company LLC reissued a buy rating and set a $11.00 price objective on shares of GenMark Diagnostics in a report on Tuesday, July 31st. Finally, Zacks Investment Research lowered GenMark Diagnostics from a hold rating to a sell rating in a report on Wednesday, July 18th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company’s stock. GenMark Diagnostics presently has an average rating of Hold and a consensus target price of $10.50.

  • [By Max Byerly]

    BidaskClub cut shares of GenMark Diagnostics (NASDAQ:GNMK) from a buy rating to a hold rating in a research note issued to investors on Tuesday.

    GNMK has been the subject of several other research reports. Zacks Investment Research downgraded shares of GenMark Diagnostics from a hold rating to a sell rating in a research note on Wednesday, July 18th. Canaccord Genuity boosted their price target on shares of GenMark Diagnostics from $9.00 to $10.00 and gave the stock a buy rating in a research note on Tuesday, July 31st. Needham & Company LLC restated a buy rating and issued a $11.00 price target on shares of GenMark Diagnostics in a research note on Tuesday, July 31st. Finally, ValuEngine upgraded shares of GenMark Diagnostics from a strong sell rating to a sell rating in a research note on Friday, August 10th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus target price of $10.50.

  • [By Shane Hupp]

    GenMark Diagnostics (NASDAQ:GNMK) was upgraded by analysts at ValuEngine from a strong sell rating to a sell rating.

    Hawaiian (NASDAQ:HA) was upgraded by analysts at ValuEngine from a strong sell rating to a sell rating.

  • [By Max Byerly]

    Citadel Advisors LLC lifted its position in GenMark Diagnostics, Inc (NASDAQ:GNMK) by 92.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 126,784 shares of the medical equipment provider’s stock after purchasing an additional 60,991 shares during the quarter. Citadel Advisors LLC owned about 0.23% of GenMark Diagnostics worth $808,000 at the end of the most recent quarter.

Top 5 Undervalued Stocks To Buy Right Now: PDC Energy, Inc.(PDCE)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PDC Energy (PDCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    An issue of PDC Energy Inc (NASDAQ:PDCE) debt fell 1% against its face value during trading on Friday. The debt issue has a 6.125% coupon and is set to mature on September 15, 2024. The debt is now trading at $97.50 and was trading at $99.63 one week ago. Price moves in a company’s debt in credit markets sometimes anticipate parallel moves in its share price.

  • [By Ethan Ryder]

    Great West Life Assurance Co. Can decreased its position in PDC Energy Inc (NASDAQ:PDCE) by 2.0% in the 2nd quarter, HoldingsChannel reports. The fund owned 83,880 shares of the energy producer’s stock after selling 1,700 shares during the period. Great West Life Assurance Co. Can’s holdings in PDC Energy were worth $5,071,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Logan Wallace]

    News articles about PDC Energy (NASDAQ:PDCE) have trended somewhat positive this week, Accern reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PDC Energy earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the energy producer an impact score of 46.6251700229584 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Ethan Ryder]

    PDC Energy (NASDAQ:PDCE) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    REDHILL BIOPHAR/S (NASDAQ:RDHL) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PDC Energy (PDCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks To Buy Right Now: ADTRAN Inc.(ADTN)

Advisors’ Opinion:

  • [By Max Byerly]

    ADTRAN, Inc. (NASDAQ:ADTN) has been assigned an average rating of “Hold” from the eleven ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $18.38.

  • [By Stephan Byrd]

    ADTRAN (NASDAQ: ADTN) and One Horizon Group (NASDAQ:OHGI) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability and analyst recommendations.

  • [By Max Byerly]

    ADTRAN, Inc. (NASDAQ:ADTN) has been assigned an average rating of “Hold” from the eleven ratings firms that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $19.38.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on ADTRAN (ADTN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks To Buy Right Now: Towerstream Corporation(TWER)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Global Eagle Entertainment (OTCMKTS: TWER) and Towerstream (OTCMKTS:TWER) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, earnings and profitability.

Leave a Reply

Your email address will not be published.